Karen Byer Eisenberg

749 total citations
16 papers, 612 citations indexed

About

Karen Byer Eisenberg is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Karen Byer Eisenberg has authored 16 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Karen Byer Eisenberg's work include Estrogen and related hormone effects (8 papers), HER2/EGFR in Cancer Research (7 papers) and Breast Cancer Treatment Studies (5 papers). Karen Byer Eisenberg is often cited by papers focused on Estrogen and related hormone effects (8 papers), HER2/EGFR in Cancer Research (7 papers) and Breast Cancer Treatment Studies (5 papers). Karen Byer Eisenberg collaborates with scholars based in United States. Karen Byer Eisenberg's co-authors include Louis P. Pertschuk, Joseph Feldman, Anne C. Carter, Dong S. Kim, Geoffrey L. Greene, Richard J. Macchia, Jay M. Fleisher, William L. Thelmo, L P Pertschuk and Eric Gaetjens and has published in prestigious journals such as Cancer, Journal of Histochemistry & Cytochemistry and Annals of Surgical Oncology.

In The Last Decade

Karen Byer Eisenberg

15 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Byer Eisenberg United States 12 296 266 188 183 136 16 612
McGuire Wl United States 14 485 1.6× 424 1.6× 328 1.7× 309 1.7× 71 0.5× 23 891
Susan M. Thorpe Denmark 22 409 1.4× 364 1.4× 245 1.3× 278 1.5× 57 0.4× 33 913
P. Cannon United Kingdom 7 183 0.6× 294 1.1× 181 1.0× 123 0.7× 53 0.4× 10 496
Mariko Nishio Japan 10 208 0.7× 394 1.5× 272 1.4× 240 1.3× 88 0.6× 12 621
S K Mohsin United States 10 332 1.1× 346 1.3× 399 2.1× 268 1.5× 64 0.5× 22 797
Maddalena T. Tilli United States 12 268 0.9× 280 1.1× 300 1.6× 112 0.6× 43 0.3× 17 596
Lavina Bharwani Singapore 9 289 1.0× 491 1.8× 356 1.9× 149 0.8× 179 1.3× 13 861
Catherine Andrieu France 10 141 0.5× 434 1.6× 427 2.3× 382 2.1× 138 1.0× 11 916
Birgit Olsson Sweden 12 146 0.5× 272 1.0× 527 2.8× 207 1.1× 145 1.1× 13 726
Osborne Ck United States 6 164 0.6× 185 0.7× 180 1.0× 136 0.7× 32 0.2× 8 396

Countries citing papers authored by Karen Byer Eisenberg

Since Specialization
Citations

This map shows the geographic impact of Karen Byer Eisenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Byer Eisenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Byer Eisenberg more than expected).

Fields of papers citing papers by Karen Byer Eisenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Byer Eisenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Byer Eisenberg. The network helps show where Karen Byer Eisenberg may publish in the future.

Co-authorship network of co-authors of Karen Byer Eisenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Byer Eisenberg. A scholar is included among the top collaborators of Karen Byer Eisenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Byer Eisenberg. Karen Byer Eisenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pertschuk, L P, Joseph Feldman, Richard J. Macchia, et al.. (1995). Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis.. PubMed. 73(2). 302–5. 51 indexed citations
2.
Pertschuk, Louis P., Richard J. Macchia, Joseph Feldman, et al.. (1994). Immunocytochemical assay for androgen receptors in prostate cancer: A prospective study of 63 cases with long-term follow-up. Annals of Surgical Oncology. 1(6). 495–503. 25 indexed citations
3.
Pertschuk, L P, et al.. (1994). Estrogen receptor immunocytochemistry: the promise and the perils.. PubMed. 19. 134–7. 14 indexed citations
4.
Pertschuk, Louis P., Dong S. Kim, Karen Byer Eisenberg, et al.. (1993). Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene relationship to disease-free survival in breast cancer. Cancer. 71(1). 162–171. 29 indexed citations
6.
Pertschuk, Louis P., Karen Byer Eisenberg, Anne C. Carter, et al.. (1988). Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response. Cancer. 62(2). 342–349. 54 indexed citations
7.
Feldman, Joseph, Louis P. Pertschuk, Anne C. Carter, Karen Byer Eisenberg, & Jay M. Fleisher. (1986). Histochemical estrogen binding An independent predictor of recurrence and survival in stage II breast cancer. Cancer. 57(5). 911–916. 5 indexed citations
8.
Pertschuk, Louis P., Karen Byer Eisenberg, Anne C. Carter, & Joseph Feldman. (1985). Heterogeneity of estrogen binding sites in breast cancer: Morphologic demonstration and relationship to endocrine response. Breast Cancer Research and Treatment. 5(2). 137–147. 33 indexed citations
9.
Pertschuk, Louis P., Karen Byer Eisenberg, Anne C. Carter, & Joseph Feldman. (1985). Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer. 55(7). 1513–1518. 134 indexed citations
10.
Pertschuk, Louis P., Karen Byer Eisenberg, Richard J. Macchia, & Joseph Feldman. (1985). Heterogeneity of steroid binding sites in prostatic carcinoma: Morphological demonstration and clinical implications. The Prostate. 6(1). 35–47. 18 indexed citations
11.
Pertschuk, Louis P., Hannah Rosenthal, Richard J. Macchia, et al.. (1982). Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer:Relation to therapeutic response. Cancer. 49(5). 984–993. 35 indexed citations
12.
Pertschuk, Louis P., Ellis Tobin, Anne C. Carter, et al.. (1981). Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: A reappraisal. Breast Cancer Research and Treatment. 1(4). 297–314. 23 indexed citations
13.
Pertschuk, L P, Ellis Tobin, Patima Tanapat, et al.. (1980). Histochemical analyses of steroid hormone receptors in breast and prostatic carcinoma.. Journal of Histochemistry & Cytochemistry. 28(8). 799–810. 46 indexed citations
14.
Eisenberg, Karen Byer, et al.. (1973). [Gamma-glutamyl-transpeptidase activity in liver diseases].. PubMed. 68(24). 798–804. 2 indexed citations
15.
Kutter, D, et al.. (1973). Die Brauchbarkeit eines neuen Teststreifens zum Nachweis von Urobilinogen im Harn. DMW - Deutsche Medizinische Wochenschrift. 98(3). 112–114. 2 indexed citations
16.
Eisenberg, Karen Byer, et al.. (1973). [The significance of the gamma-glutamyl-transpeptidase for the differential diagnosis of chronic aggressive and chronic persistent hepatitis (author's transl)].. PubMed. 68(34). 1105–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026